FECH Expression Correlates with the Prognosis and Tumor Immune Microenvironment in Clear Cell Renal Cell Carcinoma

Table 2

Logistic regression analysis of FECH expression.

Characteristics	Total (N)	Odds ratio (OR)	-Value
T stage (T3 and T4 vs. T1 and T2)	539	0.435 (0.301–0.623)	<0.001
N stage (N1 vs. N0)	257	1.078 (0.385–3.019)	0.885
M stage (M1 vs. M0)	506	0.501 (0.300–0.820)	0.007
Pathologic stage (Stage III and Stage IV vs. Stage I and Stage II)	536	0.407 (0.284–0.582)	<0.001
Primary therapy outcome (SD and PR and CR vs. PD)	147	3.927 (1.083–18.531)	0.050
Histologic grade (G3 and G4 vs. G1 and G2)	531	0.600 (0.425–0.845)	0.004
Age (>60 vs. ≤60)	539	0.856 (0.610–1.199)	0.366
Gender (male vs. female)	539	0.882 (0.618–1.258)	0.488
Laterality (right vs. left)	538	1.076 (0.767–1.511)	0.670